Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38, which is overexpressed in multiple myeloma cells. From Wikipedia
Strong cancer drug sales drive earnings beat, but profit guidance is lowered due to tariffs and acquisition-related costs.
